Compound preparation used for treating chronic kidney diseases and preparation method thereof

A technology for chronic kidney disease and compound preparation, which is applied in the field of compound preparation for the treatment of chronic kidney disease and its preparation, can solve the problems of reduced content of main drug components, slow product disintegration, low dissolution rate and the like, and avoids the increase of related substances. , to meet the needs of large production, to overcome the effect of high viscosity

Active Publication Date: 2011-04-20
BEIJING WINSUNNY PHARMA CO LTD
View PDF5 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. Calcium ketoacids and amino acids are directly mixed to easily interact, and reactions such as calcium ketoacids and amino acid degradation occur, resulting in a decrease in the content of the main ingredient and an increase in related substances
[0005] 2. Calcium ketoacid has a relatively high viscosity, especially when it meets water, the viscosity is even greater, and wet granulation will cause serious agglomeration, which cannot be made into granules that meet the requirements, which will affect tableting and is not suitable for scale-up production.
[0006] 3. The high viscosity of the material leads to slow disintegration and low dissolution rate of the product
[0007] 200710163357.1 discloses a compound α-keto acid chewable tablet and its preparation method. It adopts the process of mixing and granulating keto acid calcium, amino acid and pharm

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0066] Prescription process 1 (provided by the invention)

[0067] calcium ketoate fraction

[0068] Calcium Alpha-Rac-Keto-Isoleucine 67g

[0069]Calcium alpha-ketoleucine 101g

[0070] Calcium alpha-ketophenylalanine 68g

[0071] Alpha Ketovaline Calcium 86g

[0072] Calcium alpha-racemic hydroxymethionine 59g

[0073] Polyethylene glycol 29g

[0074] Talc powder 33g

[0075] Microcrystalline Cellulose 20g

[0076] 11g pregelatinized starch

[0077] Sodium carboxymethyl starch 10g

[0078] Absolute ethanol 32g

[0079] Magnesium Stearate 4g

[0080] amino acid moiety

[0081] L-Lysine Acetate 105g

[0082] L-Threonine 53g

[0083] L-Tryptophan 23g

[0084] L-histidine 38g

[0085] L-Tyrosine 30g

[0086] Microcrystalline Cellulose 22g

[0087] Sodium carboxymethyl starch 4g

[0088] Pregelatinized starch 24g

[0089] Povidone 8g

[0090] Magnesium Stearate 3g

[0091] The preparation steps are as follows:

[0092] 1. Preparation of calcium ketoacids: We...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound preparation used for treating chronic kidney diseases and a preparation method thereof. The preparation has the advantages of beautiful appearance, fast disintegration speed, high dissolution rate and high and stable content of active ingredients. The method that calcium ketonate and amino acid are respectively granulated is adopted, interaction of components is avoided, and the contents of active ingredients can be ensured to be stable. The calcium ketonate part contains anti-viscosity ingredients and an anhydrous wetting agent, the granulation problem caused by the facts that the calcium ketonate is easy to agglomerate due to high viscosity is solved, and meanwhile the disintegration speed and dissolution rate of the preparation are improved, the product quality can be ensured, and the requirement of large scale production can be met.

Description

technical field [0001] The invention relates to a compound preparation for treating chronic kidney disease and a preparation method thereof, belonging to the field of pharmaceutical preparations. Background technique [0002] In recent years, chronic kidney disease (CKD) has a high incidence rate and tends to be younger, and it has been paid more and more attention by people. The progress of CKD is hidden. Once it enters the advanced stage, the cost of treatment drugs and nursing care will surge. Compound α-ketoacid tablets combined with a low-protein diet can delay the progression of renal failure, which is of great value in the treatment of CKD and has gradually become the core means of CKD treatment. [0003] Compound α-keto acid is a compound preparation containing ten active ingredients including 4 kinds of ketoamino acid calcium, 1 hydroxyamino acid calcium and five essential amino acids, which are α-racemic ketoisoleucine calcium, α-ketone Calcium Leucine, Calcium A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4172A61K31/405A61K31/19A61K31/192A61K31/198A61K9/28A61K9/48A61P13/12
Inventor 黄河
Owner BEIJING WINSUNNY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products